ACC in Space with NASA
One of the greatest challenges of space exploration is personning long space missions due to the health damage the human body suffers from spending a long time in space
Amorphical’s groundbreaking research helps address the health issues caused by prolonged space travel
The extreme conditions outside’s Earth atmosphere cause multiple health issues for the human body. During the first days of zero gravity, astronauts report adverse events such as nausea, vomiting, headache and fatigue. These symptoms usually pass after 3 days or so, but the long-term health damage – rapid loss of bone and muscle mass – remains unaddressed.
The reason for the rapid loss of bone mass in space is a decreased division rate of osteoblasts (bone-building cells) – 55 as opposed to 114 on Earth. The lower the osteoblast division rate, the slower new bone is built.
Many people in the modern world look for ways to increase their bone mass in order to strengthen their body, minimize the risk of osteoporosis and prevent fractures. One of the ways to do that is to add a calcium supplement to the daily diet.
Until today, all the known and available calcium supplements were crystalline, which means they deposit in the blood without reaching the target organ, and have low bioavailability and low efficacy. The only non-crystalline calcium supplement in the world is DENSITY, made up of nano amorphous calcium carbonate (ACC). Its unique structure and combination of minerals increase its bioavailability, improving its solubility and making it more efficient in reaching the target organ and addressing the problem.
After investing great resources and many years of research and filing dozens of patents, Amorphical succeeded in developing a unique new revolutionary substance and making it suitable for human use. The results speak for themselves in proven trial findings and user stories.
Amorphical has taken part in NASA’s Spacelab study which tested the efficacy of ACC for astronauts in space. The results showed the osteoblast division rate improved significantly and almost reached the normal Earth rate. This study proves that DENSITY, nano amorphous calcium carbonate, is efficient even in space, helping astronauts maintain their bone building rate and minimize bone loss associated with space travel. These encouraging results shall help increase the time humans can spend in space and significantly aid worldwide space research. NASA and Amorphical are currently planning their further collaboration.